Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
369
datasets available to search
ShareScore release 0.9.0
Dataset results
369 results for “adalimumab”
Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate
ClinicalTrials.gov study NCT02393378. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
ClinicalTrials.gov study NCT01114880. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept
ClinicalTrials.gov study NCT00927069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA® (Adalimumab) 40 mg/0.4 mL in Healthy Chinese Adult Participants Under Fasting Conditions
ClinicalTrials.gov study NCT07147257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy
ClinicalTrials.gov study NCT01156532. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
ClinicalTrials.gov study NCT00235872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety
ClinicalTrials.gov study NCT01712178. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)
ClinicalTrials.gov study NCT02471118. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis
ClinicalTrials.gov study NCT05105347. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00237887. IPD Sharing: Not stated. Countries: 0. Publications: 5.
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational S
ClinicalTrials.gov study NCT01083160. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT01078116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT02833350. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01265823. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
ClinicalTrials.gov study NCT00513370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT00448383. IPD Sharing: Not stated. Countries: 0. Publications: 3.
A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT00853099. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator
ClinicalTrials.gov study NCT02413047. IPD Sharing: NO. Countries: 1. Publications: 0.
A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)
ClinicalTrials.gov study NCT03258814. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)
ClinicalTrials.gov study NCT00427921. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.